Overall, Black / African American people have slightly higher incidence rates of primary brain and other CNS tumors at 23.88 per 100,000 followed by:
Despite the number of brain tumors, and their devastating prognosis, there are only five FDA approved drugs – and one device – to treat brain tumors.
For many tumor types, surgery and radiation remain the standard of care.
Primary brain and other CNS tumors are not staged, but classified according to the WHO Classification of Tumors of the Central Nervous System, which assigns a “grade” of I-IV, based on how aggressive the tumor is predicted to behave.
Public Law 107-260, Benign Brain Tumor Cancer Registries Amendment Act requires the collection of benign brain tumors in cancer registries. The reason for reporting are:
Meningiomas are the most commonly occurring primary non-malignant brain tumors, accounting for:
Tumors of the pituitary are the most prevalent brain tumor types in adolescents (15-19)
The most prevalent brain tumor types in children are:
Glioblastoma (GBM) is the most common primary malignant brain tumor (brain cancer):
The average survival rate for all primary brain tumor patients is 75.2%
Pediatric Brain Tumors are the most common solid cancer among children and adolescents age 0-19 years
Brain Tumors are the leading cause of cancer-related death among children and adolescents ages 0-19 years
An estimated 18,600 people will die from a malignant brain tumor (brain cancer) in 2021
An estimated 84,170 people will receive a primary brain tumor diagnosis in 2021
An estimated 700,000 Americans are living with a primary brain tumor: